AAAAAA
Results:
1-7
|
Results: 7
Authors:
Blaney, S
Berg, SL
Pratt, C
Weitman, S
Sullivan, J
Luchtman-Jones, L
Bernstein, M
Citation: S. Blaney et al., A phase I study of irinotecan in pediatric patients: A Pediatric Oncology Group Study, CLIN CANC R, 7(1), 2001, pp. 32-37
Authors:
Kerr, JZ
Berg, SL
Dauser, R
Nuchtern, J
Egorin, MJ
McGuffey, A
Aleksic, A
Blaney, S
Citation: Jz. Kerr et al., Plasma and cerebrospinal fluid pharmacokinetics of gemcitabine after intravenous administration in nonhuman primates, CANC CHEMOT, 47(5), 2001, pp. 411-414
Authors:
Long, L
Berg, SL
Roy, SK
McCully, CL
Song-Yoo, HW
Moschel, RC
Balis, FM
Dolan, ME
Citation: L. Long et al., Plasma and cerebrospinal fluid pharmacokinetics of O-6-benzylguanine and analogues in nonhuman primates, CLIN CANC R, 6(9), 2000, pp. 3662-3669
Authors:
Riva, L
Blaney, SM
Dauser, R
Nuchtern, JG
Durfee, J
McGuffey, L
Berg, SL
Citation: L. Riva et al., Pharmacokinetics and cerebrospinal fluid penetration of CI-994 (N-acetyldinaline) in the nonhuman primate, CLIN CANC R, 6(3), 2000, pp. 994-997
Authors:
Berg, SL
Blaney, SM
Sullivan, J
Bernstein, M
Dubowy, R
Harris, MB
Citation: Sl. Berg et al., Phase II trial of pyrazoloacridine in children with solid tumors: A Pediatric Oncology Group phase II study, J PED H ONC, 22(6), 2000, pp. 506-509
Authors:
Berg, SL
Reid, J
Godwin, K
Murry, DJ
Poplack, DG
Balis, FM
Ames, MM
Citation: Sl. Berg et al., Pharmacokinetics and cerebrospinal fluid penetration of daunorubicin, idarubicin, and their metabolites in the nonhuman primate model, J PED H ONC, 21(1), 1999, pp. 26-30
Authors:
Kitchen, BJ
Moser, A
Lowe, E
Balis, FM
Widemann, B
Anderson, L
Strong, J
Blaney, SM
Berg, SL
O'Brien, M
Adamson, PC
Citation: Bj. Kitchen et al., Thioguanine administered as a continuous intravenous infusion to pediatricpatients is metabolized to the novel metabolite 8-hydroxy-thioguanine, J PHARM EXP, 291(2), 1999, pp. 870-874
Risultati:
1-7
|